By the same authors

From the same journal

Is treatment of depression cost-effective in people with diabetes? A systematic review of the economic evidence

Research output: Contribution to journalArticle

Published copy (DOI)

Author(s)

  • Farheen Jeeva
  • Christopher Dickens
  • Peter Coventry
  • Christine Bundy
  • Linda Davies

Department/unit(s)

Publication details

JournalInternational Journal of Health Technology Assessment
DatePublished - Oct 2013
Issue number4
Volume29
Number of pages8
Pages (from-to)384-391
Original languageEnglish

Abstract

OBJECTIVES: Depression is common in diabetes and linked to a wide range of adverse outcomes. UK policy indicates that depression should be treated using conventional psychological treatments in a stepped care framework. This review aimed to identify current economic evidence of psychological treatments for depression among people with diabetes.

METHOD: Electronic search strategies (conducted in MEDLINE, EMBASE, PsycINFO, CINAHL, NHS EED) combined clinical and economic search terms to identify full economic evaluations of the relevant interventions. Prespecified screening and inclusion criteria were used. Standardized data extraction and critical appraisal were conducted and the results summarized qualitatively.

RESULTS: Excluding duplicates, 1,516 studies for co-morbid depression and diabetes were screened. Four economic evaluations were identified. The studies found that the interventions improved health status, reduced depression and were cost-effective compared with usual care. The studies were all U.S.-based and evaluated collaborative care programs that included psychological therapies. Critical appraisal indicated limitations with the study designs, analysis and results for all studies.

CONCLUSIONS: The review highlighted the paucity of evidence in this area. The four studies indicated the potential of interventions to reduce depression and be cost-effective compared with usual care. Two studies reported costs per QALY gained of USD 267 to USD 4,317, whilst two studies reported the intervention dominated usual care, with net savings of USD 440 to USD 612 and net gains in patient free days or QALYs.

    Research areas

  • Aged, Cost-Benefit Analysis, Depressive Disorder, Major, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Outcome Assessment (Health Care), Quality-Adjusted Life Years

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations